Reasons for Declining to Enroll in an HIV Vaccine Trial in Tanzania
Author Information
Author(s): Tarimo Edith A. M., Thorson Anna, Kohi Thecla W., Bakari Muhammad, Mhalu Fred, Kulane Asli
Primary Institution: Karolinska Institutet, Stockholm, Sweden
Hypothesis
What are the reasons individuals decline to enroll in an HIV vaccine trial after being randomized?
Conclusion
Fear of negative outcomes from the vaccine and resistance from significant others are the main reasons for declining to enroll in the HIV vaccine trial.
Supporting Evidence
- Participants expressed fear of the vaccine's effects on their health.
- Resistance from significant others was a common theme among those who declined.
- Men were more concerned about the vaccine's impact on their reproductive intentions than women.
- Women were influenced by their intimate partners' opinions.
- Concerns about health insurance and potential side effects were prevalent.
- Informants reported feeling guilty about not proceeding with the trial due to social pressures.
Takeaway
People were scared of what might happen if they took the HIV vaccine and were also influenced by their family and friends who didn't want them to participate.
Methodology
Face-to-face interviews were conducted with 14 individuals, and data was analyzed using content analysis.
Potential Biases
Potential bias due to the influence of significant others on participants' decisions.
Limitations
The results cannot be generalized beyond the context studied, and the sample may not represent all who declined to enroll.
Participant Demographics
Participants included 7 men and 7 women aged 20-38, with a mean age of 28 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website